Page last updated: 2024-08-16

ribavirin and thiophenes

ribavirin has been researched along with thiophenes in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's9 (75.00)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Barascut, JL; Cappellacci, L; Dukhan, D; Franchetti, P; Goldstein, BM; Grifantini, M; Imbach, JL; Jayaram, HN; Marchetti, S; Yalowitz, JA1
Cooper, C1
Appleby, TC; Bidgood, AM; Byun, D; Canales, E; Clarke, MO; Doerffler, E; Eng, S; Fenaux, M; Hashash, A; Krawczyk, SH; Lazerwith, SE; Leavitt, SA; Lee, YJ; Lew, W; Liu, Q; Mabery, EM; Matles, M; Mertzman, M; Morganelli, P; Murray, BP; Mwangi, J; Tian, Y; Watkins, WJ; Xu, L; Ye, H; Zhang, J1
Alves, K; Asmal, M; DeSouza, C; Di Bisceglie, AM; Gane, E; George, S; Jacobson, IM; Kauffman, R; Kieffer, T; Koziel, MJ; Nelson, D; Sulkowski, M; Zhang, EZ1
Cummins, N; Dabo, AJ; Foronjy, RF; Geraghty, P; Taggart, CC; Weldon, S1
Delaney, W; Dvory-Sobol, H; Lawitz, EJ; Mabery, E; McHutchison, J; Miller, MD; Mo, H; Skurnac, T; Svarovskaia, ES; Voitenleitner, C1
Foster, GR1
Abbott, S; Barrett, LL; Bon, D; Chavez, J; Diaz, G; Egerson, D; Fauci, AS; Gross, C; Herrmann, E; Jolley, TA; Kapoor, R; Kleiner, DE; Kohli, A; Kotb, C; Kottilil, S; Kwan, R; Marti, MM; Masur, H; McHutchison, J; Meissner, EG; Nelson, A; Osinusi, A; Pang, PS; Petersen, T; Polis, MA; Proschan, M; Sidharthan, S; Silk, R; Sims, Z; Sneller, M; Spurlin, E; Subramanian, GM; Symonds, WT; Talwani, R; Teferi, G; Townsend, K; Wood, BJ1
Kohli, A; Kottilil, S; Masur, H; Meissner, EG; Osinusi, A; Remaley, AT; Sampson, M; Sidharthan, S; Tang, L; Townsend, K1
Han, M; Huang, W; Li, X; Wu, X; Yu, F; Zhao, X1
Leonova, GN; Lubova, VA; Maistrovskaya, OS1
Cheng, Y; Cui, M; Ding, Y; He, W; Li, L; Li, X; Li, Z; Tian, A; Yang, C; Zhao, Z; Zou, X1

Reviews

1 review(s) available for ribavirin and thiophenes

ArticleYear
Viral response to specifically targeted antiviral therapy for hepatitis C and the implications for treatment success.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2010, Volume: 24, Issue:6

    Topics: Animals; Antiviral Agents; Carboxylic Acids; Drug Resistance, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Protease Inhibitors; Remission Induction; Ribavirin; Thiophenes; Treatment Outcome

2010

Trials

5 trial(s) available for ribavirin and thiophenes

ArticleYear
Preclinical characterization of GS-9669, a thumb site II inhibitor of the hepatitis C virus NS5B polymerase.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2

    Topics: Animals; Antiviral Agents; Cell Line, Tumor; Dogs; Drug Resistance, Viral; Furans; Hepacivirus; Humans; Interferon-alpha; Male; Mutation; Polymorphism, Single Nucleotide; Pyrones; Rats; Rats, Sprague-Dawley; Ribavirin; RNA-Dependent RNA Polymerase; Thiophenes; Triazoles; Viral Nonstructural Proteins

2013
VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection.
    European journal of gastroenterology & hepatology, 2014, Volume: 26, Issue:7

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Cyclohexanols; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thiophenes; Treatment Outcome; Viral Nonstructural Proteins; Young Adult

2014
Clinical and in vitro resistance to GS-9669, a thumb site II nonnucleoside inhibitor of the hepatitis C virus NS5B polymerase.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Adult; Antiviral Agents; Base Sequence; Benzimidazoles; Cell Line; Drug Resistance, Viral; Female; Fluorenes; Furans; Genetic Variation; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Protein Binding; Quinolines; Ribavirin; Sequence Analysis, RNA; Sofosbuvir; Thiophenes; Treatment Outcome; Uridine Monophosphate; Viral Nonstructural Proteins

2014
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study.
    Lancet (London, England), 2015, Mar-21, Volume: 385, Issue:9973

    Topics: Aged; Antiviral Agents; Benzimidazoles; Cohort Studies; Drug Therapy, Combination; Female; Fluorenes; Furans; Hepacivirus; Hepatitis C, Chronic; Humans; Intention to Treat Analysis; Male; Middle Aged; Quinolines; Ribavirin; RNA, Viral; Sofosbuvir; Thiophenes; Treatment Outcome; Uridine Monophosphate; Viral Load

2015
Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration.
    AIDS research and human retroviruses, 2016, Volume: 32, Issue:5

    Topics: Antiviral Agents; Benzimidazoles; Cardiovascular Diseases; Cholesterol, LDL; Coinfection; Drug Therapy, Combination; Dyslipidemias; Female; Fluorenes; Furans; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Male; Middle Aged; Prospective Studies; Quinolines; Ribavirin; Sofosbuvir; Thiophenes; Uridine Monophosphate

2016

Other Studies

6 other study(ies) available for ribavirin and thiophenes

ArticleYear
Synthesis, conformational analysis, and biological activity of C-thioribonucleosides related to tiazofurin.
    Journal of medicinal chemistry, 2000, Apr-06, Volume: 43, Issue:7

    Topics: Antineoplastic Agents; Drug Screening Assays, Antitumor; Furans; Glycosylation; Humans; IMP Dehydrogenase; Magnetic Resonance Spectroscopy; Molecular Conformation; Ribavirin; Ribonucleosides; Ribose; Structure-Activity Relationship; Thermodynamics; Thiophenes; Tumor Cells, Cultured

2000
Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors.
    Mucosal immunology, 2015, Volume: 8, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Adaptor Proteins, Vesicular Transport; Animals; Cathepsins; DEAD Box Protein 58; DEAD-box RNA Helicases; Gene Expression Regulation, Viral; Interferon Type I; Leucine; Lung; Matrix Metalloproteinases; Mice; Mice, Inbred Strains; Mice, Knockout; Phenylalanine; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Ribavirin; Thiophenes; Viral Load

2015
Shorter treatments for hepatitis C: another step forward?
    Lancet (London, England), 2015, Mar-21, Volume: 385, Issue:9973

    Topics: Antiviral Agents; Benzimidazoles; Female; Fluorenes; Furans; Hepatitis C, Chronic; Humans; Male; Quinolines; Ribavirin; RNA, Viral; Sofosbuvir; Thiophenes; Uridine Monophosphate

2015
Synthesis of a Novel Class of 1,3-oxathiolane Nucleoside Derivatives of T- 705 and Evaluation of Their Anti-influenza A Virus and Anti-HIV Activity.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2018, Volume: 14, Issue:6

    Topics: Amides; Animals; Anti-HIV Agents; Dogs; HEK293 Cells; HIV; Humans; Influenza A Virus, H1N1 Subtype; Isomerism; Madin Darby Canine Kidney Cells; Nucleosides; Pyrazines; Ribavirin; Thiophenes

2018
Molecular and Genetic Bases of Inhibition of Tick-Borne Encephalitis Virus Replication by Eprosartan and Ribavirin.
    Bulletin of experimental biology and medicine, 2020, Volume: 170, Issue:1

    Topics: Acrylates; Animals; Antiviral Agents; Cell Line; Cell Survival; Encephalitis Viruses, Tick-Borne; Epithelial Cells; Imidazoles; Kidney; Microbial Sensitivity Tests; Ribavirin; Swine; Thiophenes; Virus Replication

2020
Anti-influenza virus activity of the REV-ERBĪ± agonist SR9009 and related analogues.
    Antiviral research, 2022, Volume: 207

    Topics: Adamantane; Antiviral Agents; ARNTL Transcription Factors; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Interferons; Oseltamivir; Pyrrolidines; Ribavirin; Thiophenes

2022